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Abstract Xenopus laevis are a rich resource for vertebrate
embryology and cell biology. Transplantation and transgenesis
have provided much information about the developmental
mechanisms of embryogenesis and molecule function, however
existing methods have faced limitations regarding either the
precise localization of gene expression or flexibility in the timing
of gene transfer. Here we have found that electroporation of
tailbud (stage 29/30) embryos is a rapid and efficient method of
combining cell-specific expression with variation in temporal
delivery. At the low voltages required for electroporation,
embryos resumed normal swimming behavior and development.
We conclude that electroporation has wide experimental ap-
plication to Xenopus developmental and cell biology. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
The tailbud stage of Xenopus (Nieuwkoop and Faber stage
29/30 [1]) is a useful stage for studying molecular contribu-
tions to cell migration, body patterning and organogenesis,
yet relative few methods exist for precise spatial and temporal
control of gene expression. Electroporation is a method of
delivering brief electric ¢eld impulses to cells or tissue to allow
DNA, enzymes, antibodies and other macromolecules to enter
cells [2]. In other experimental systems, electroporation has
o¡ered advantages over viral methods of gene delivery by
its immediate e¡ects, lack of immunogenicity and unrestricted
DNA size [3]. Also, electroporation appears equivalent or
superior to other non-viral gene delivery methods (lipofection,
gene gun, direct DNA injection), in terms of transfer e⁄ciency
[3]. Electroporation has most widely been applied to embry-
onic stem cells [4], cell lines [5] or primary cultures [6], how-
ever more recently it has also been successfully applied to
intact chick embryos (chick) [7,8]. In the present study, we
were interested in examining electroporation as a method of
gene delivery and macromolecule uptake in swimming stage
29/30 of Xenopus. Expression plasmids using ubiquitous or
cell-speci¢c promoters were tested.
2. Materials and methods
2.1. Animals
Xenopus embryos were generated by in vitro fertilization as previ-
ously described by Liu et al. [9]. Embryos were allowed to develop to
Nieuwkoop and Faber stages 25^29/30, were brie£y treated with
0.15% tricaine, then electroporated as described below.
2.2. Electroporation
For electroporation, embryos were placed in a 3 Wl 1UMMR [10]
þ plasmid DNA or propidium iodide (PI) (50 Wg/ml; Sigma). PI is a
useful marker of macromolecule delivery because it is impermeable to
the membranes of viable cells, yet £uorescently labels cell nuclei with
successful electroporation [11]. Plasmid DNA consisted of either pEF/
myc/cyto/GFP (Invitrogen) or pGFA2Lac-1 (gift of M. Brenner, Uni-
versity of Alabama) at 0.5^1 Wg/ml. pEF/myc/cyto/GFP is a 6.1 kb
plasmid which drives green £uorescent protein (GFP) under the con-
trol of the elongation factor 1-K promoter. pGFA2Lac-1 is an 8.5 kb
plasmid that drives the lacz gene under the control of the human glial
¢brillary acidic protein promoter [12]. An ECM 803 electroporator
(BTX, San Diego, CA, USA) was used for all experiments. Embryos
were placed in a 3 Wl drop of DNA between the tips of Genetrode
(BTX) electrodes spaced 3^4 mm apart. E¡ective electroporations
were performed at 10^20 V, 50 ms pulse length, 1 s pulse interval,
4^8 shocks. Following electroporation, embryos were photographed
using an automated £uorescent photomicrographic system from
Olympus (BX50, Lake Success, NY, USA).
PI and GFP embryos were analyzed live. For axial sections, em-
bryos were euthanized in tricaine, ¢xed in MEMFA (0.1 M MOPS,
2 mM EGTA, 1 mM MgSO4, 3.7% paraformaldehyde, pH 7.4) for 1 h,
then sectioned with a sharp microscissors.
2.3. Adeno-associated viral (AAV) injections
AAV DNA vector injections were performed as described by [13].
The nLgalITR expression vector was generously provided by Sylvia
Evans (Scripps Institute). nLgalITR consists of a plasmid containing
AAV inverted terminal repeats and the cytomegalovirus enhancer,
5P untranslated region from the L-globin gene, and nuclear-localized
lacz (L-galactosidase). Prior to injection, the plasmid was linearized
with NotI, puri¢ed by alcohol precipitation and then injected into two
cell embryos using a Nanoject injector (Drummond).
For lacz development, embryos were ¢xed in MEMFA for 1 h,
washed in 0.1 M phosphate bu¡er (PB) for 5 min, then transferred
embryos into Lgal solutions consisting of 32.93 mg potassium ferri-
cyanide, 42.24 mg potassium ferrocyanide and 0.1 ml 15% Xgal (15
mg in 100 Wl DMF) in 10 ml 0.1 M PB [13].
3. Results
3.1. Electroporation-mediated delivery comparable to
AAV-mediated transgenesis
Fig. 1 demonstrates the e⁄ciency of electroporation-medi-
ated delivery compared to conventional transgenic methods.
Fig. 1A^C shows the head regions of stage 29/30 embryos
expressing nuclear Lacz (A), vector control (B) or electropo-
rated PI (C). Fig. 1D^F shows representative back regions of
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Fig. 1. E⁄ciency of electroporation-mediated PI delivery. A^C shows the head regions of stage 29/30 embryos expressing Lacz (AAV transgene-
sis), vector control (B), or electroporated PI (C, 20 V, 8 pulses). Representative back regions of these embryos are shown in D^F. G and H
show e⁄cient delivery by electroporation throughout the embryo in the axial plane. G and H are control (G) and electroporated (H, 20 V,
8 pulses) embryos that had been incubated brie£y while live in PI, euthanized, ¢xed and sectioned. The asterisk in G shows non-speci¢c PI
staining in ¢xed epidermis. p, pronephric anlage, s, somite, sc, spinal cord, y, yolk mass. A bright¢eld view is shown in I.
Fig. 2. E¡ect of shock number on electroporation-mediated delivery. A and B show the correlation of pulse number with the quantity of PI de-
livered to the nucleus. A and B are photographs of a single embryo after 4 (A) and 8 (B) pulses. All other electroporation parameters were
held constant (20 V, 50 ms). At higher voltages (25 V) some tissue injury could be detected in embryos by irregularities in PI staining or kink-
ing of tails. C shows a line of condensed PI-stained nuclei (asterisk) thought to re£ect early apoptotic changes. D is a high magni¢cation view
of the asterisked region shown in C (arrows). E is a similar high magni¢cation view of an embryo electroporated at lower voltage (20 V).
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conventional transgenic (D), control (E) or electroporated (F)
embryos. At 250 V/cm, 50 ms pulse length, 1 s pulse interval,
pulse number 8, electroporation caused a robust and uniform
uptake of PI throughout the embryo, with more de¢nite and
homogeneous labeling of each nuclei than seen with AAV
plasmid injections (A). Under the optimal electroporation
conditions, 100% of stage 29/30 embryos showed prominent
PI nuclear staining, and few deaths occurred (3%, n = 60). In
some cases, the brief exposure to tricaine may have contrib-
uted to deaths. No untoward e¡ects were observed from elec-
troporation at this setting, embryos awakened within seconds
to minutes of electroporation/tricaine anesthesia, quickly re-
suming normal swimming and escape behaviors. Fig. 1G^I
showed electroporation was able to deliver in a fairly uniform
fashion throughout the embryo. The asterisk in Fig. 1G shows
non-speci¢c PI labeling (MEMFA-¢xed) of PI-treated (but
non-electroporated) controls. Control embryos were incu-
bated in PI, but not electroporated. Fig. 1H shows that elec-
troporation mediated fairly uniform delivery of PI throughout
the embryo, including the spinal cord (sc), somites (s), pro-
nephric anlage (p) and endodermal yolk mass (y). Fig. 1I is a
bright¢eld view of the electroporated embryo shown in Fig.
1H.
In all cases, electroporation at optimized levels (250 V/cm,
50 ms, 8 pulses) did not appear to a¡ect normal development.
Stage 25 (hatched) embryos were earliest and stage 35/36 the
oldest whole tadpoles to be electroporated in this study. By
stages 40^45, electroporations appeared incomplete, most
likely because of the larger size and increased thickness of
the embryos.
3.2. PI uptake is proportional to shock number; higher voltages
cause damage
Fig. 2A,B show the e¡ect of increasing pulse number on PI
uptake. At 20 V, 4 pulses (Fig. 2A), nuclear PI staining could
be seen throughout the embryo, but the overall intensity of
£uorescent staining was low, and some regional variations in
£uorescence intensity could be seen. Fig. 2B shows the same
embryo in Fig. 2A with 4 additional pulses. Increasing pulse
number greatly increased PI uptake, consistent with a manip-
ulation of shock numbers to vary macromolecule or gene
delivery.
At 25 V (600 V/cm), we began observing some tissue dam-
age from the electroporations. Some embryos developed
kinked tails, poor swimming and alterations in PI staining
within 5 h. Fig. 2C,D are low and high magni¢cation views
of an embryo with an electroporation-mediated damage (4 h
post-electroporation). Fig. 2C shows a jagged line of (asterisk)
condensed nuclei occurring in the vicinity of where the elec-
trodes were positioned. At higher magni¢cation (Fig. 2D),
condensed nuclei were seen (arrows) consistent with early ap-
optotic changes [14]. Fig. 2E shows a similar high magni¢ca-
tion view of an embryo electroporated at 20 V (250 V/cm) for
comparison.
3.3. Cell-speci¢c gene expression retained with electroporation
Fig. 3A^C demonstrates the variation in gene expression
o¡ered by di¡erent promoters in the developing eye. Fig.
3A shows the uniformity of electroporation-mediated PI up-
take in the stage 29/30 embryo. Fig. 3B,C shows the results of
electroporated DNA plasmids using di¡erent promoters (elon-
gation factor 1-K, glial ¢brillary acidic protein) analyzed at
stage 42 (3 days following electroporation). Under the elon-
gation factor 1-K promoter, GFP was expressed at high levels
in the cornea (asterisk) as well as in the surrounding neural
retina (Fig. 3B). In contrast, Fig. 3C shows a bright¢eld pho-
tograph of restricted lacz gene expression over the optic nerve
(arrow). In Xenopus optic nerve, as with most vertebrate spe-
cies, glial ¢brillary acidic protein is expressed at high levels
[15,16]. Because no neuronal cell bodies comprise the optic
nerve, intense glial-speci¢c expression can be observed over-
lying the optic nerve in whole mounts.
4. Discussion
In this paper, we conclude that electroporation is an e⁄-
cient low morbidity technique for gene and macromolecule
transfer at the tailbud stage in Xenopus. With 8 pulse repeti-
tions at 250 V/cm, 50 ms pulse interval, high levels of PI
uptake or gene delivery were achieved. Following electropo-
ration, embryos quickly resumed their normal swimming be-
haviors and were indistinguishable from non-electroporated
controls. Follow-up 2 weeks after electroporation showed no
gross developmental alterations. Cell-speci¢c expression was
retained in electroporation, so that precise temporal control of
foreign gene expression could be combined with cell-speci¢c
expression using selective promoters. In developing Xenopus,
the combination of tight spatial and temporal control may be
a powerful strategy for determining gene function during de-
velopment. Xenopus tailbud embryos may develop from the 2-
cell embryos in less than 2 days [17]. In the Xenopus retina,
only 8 h separates the cessation of DNA synthesis in the
central retina (stage 28) and arrival of the optic nerve in the
diencephalon (stage 32) [18,19]. Given the rapid pace of devel-
opment in this animal model, precise minute-to-hour control
of gene delivery can facilitate the dissection of biological
events. At present, conventional transgenic methods allow
some spatiotemporal control of gene expression [13,19], how-
ever precise cellular restriction usually o¡ers little leeway in
the timing of gene delivery, and inducible systems o¡er little
leeway in the restricting sites of expression [20]. Tetracycline-
regulated gene shuto¡ may provide one alternative to conven-
tional expression systems [21], however toxicity and the in-
completeness of gene shut-o¡ complicate this approach. In
summary, we believe that electroporation will be a powerful
addition to gene delivery techniques in developing Xenopus.
Because of the ease of use, the immediacy of gene transfer,
high and selective expression levels and low morbidity, it has
broad applications in developmental, physiological and phar-
macological studies involving this animal system.
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Fig. 3. Electroporation permits cell-speci¢c expression in the Xenopus eye. A^C show the e¡ect of electroporated PI (A), and electroporated
GFP (B) and lacz (C) plasmids in wholemount stage 42 embryos. GFP was expressed under the ubiquitous promoter elongation factor 1-K,
and lacz was expressed under the glial ¢brillary acidic protein promoter (see Section 2). The asterisk in B indicates prominent green £uores-
cence in the cornea. In C, the arrow indicates the presence of lacz staining overlying the optic nerve.
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